Researchers sought to develop and validate artificial neural networks for overall survival and progression-free survival in older adults with HNSCC following definitive chemoradiation.
Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC. Results for miRNA-only XGBoost algorithm in held-out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback